chr1-22086463-G-A
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001791.4(CDC42):c.203G>A(p.Arg68Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R68R) has been classified as Likely benign.
Frequency
Consequence
NM_001791.4 missense
Scores
Clinical Significance
Conservation
Publications
- macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDC42 | NM_001791.4 | c.203G>A | p.Arg68Gln | missense_variant | Exon 4 of 6 | ENST00000656825.1 | NP_001782.1 | |
| CDC42 | NM_001039802.2 | c.203G>A | p.Arg68Gln | missense_variant | Exon 5 of 7 | NP_001034891.1 | ||
| CDC42 | NM_044472.3 | c.203G>A | p.Arg68Gln | missense_variant | Exon 4 of 6 | NP_426359.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 68 of the CDC42 protein (p.Arg68Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of CDC42-related conditions (PMID: 29394990). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 450370). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects CDC42 function (PMID: 29394990). For these reasons, this variant has been classified as Pathogenic. -
Published functional studies demonstrate a damaging effect as p.(R68Q) significantly affected protein function and protein-protein interactions (PMID: 29394990); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36939041, 29394990) -
- -
Abnormal facial shape;C0850715:Abnormality of blood and blood-forming tissues;C1859778:Postnatal growth retardation;C4021753:Abnormality of the immune system;C4022737:Neurodevelopmental abnormality Pathogenic:1
- -
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at